Next Science Limited (ASX: NXS) is a medical technology company headquartered in Sydney, Australia, with commercial operations in Florida, USA. Next Science’s primary focus is the development and continued commercialisation of its proprietary XBIO™ technology to reduce the impact of biofilm-based infections in human health.

Shareholder communications

Next Science Continuous Disclosure Policy (Feb 2026)Opens in new window

Title Date
Notice of General MeetingOpens in new window 25 Feb 2026
 

IMPORTANT NOTICE: SHAREHOLDER RIGHTS

Shareholders have the following rights in respect of how Next Science sends shareholder meeting documentation, annual reports and certain other documents:

  • A shareholder can make a standing election to be sent all documents in electronic form or physical form;
  • A shareholder can make a one-off request to be sent shareholder meeting documentation or the annual report in electronic or physical form; and
  • A shareholder can tell us that they do not want to be sent a copy of the annual report. You will always be able to access and read our annual reports on Next Science’s website and the ASX announcements platform.

The best way for shareholders to receive meeting documentation, annual reports and other information about Next Science matters is electronically. Electronic communications are quick, environmentally friendly and cost-effective.

If you have not already provided us with your email address and elected electronic communications, please go to the Investor Centre at au.investorcentre.mpms.mufg.comOpens in new window and follow the prompts.

Next Science will send Shareholders all documents to which Division 2 of Part 1.2AA of the Corporations Act 2001 (Cth) applies (Documents) in electronic form unless the recipient Shareholder has elected to be sent Documents in physical form or elected to not be sent Documents.


Investor contacts

Investor queries

Next Science Limited
Level 14, Australia Square,
264-278 George Street, Sydney
NSW 2000
Ph: +61 412 292 977
E: [email protected]

Share Registry queries

Automic
Level 5, 126 Phillip Street
Sydney NSW 2000
Email: [email protected]
Ph (within Australia): 1300 288 664
Ph (outside Australia): +61 2 9698 5414